TAZOCIN 4.5 G

Pajjiż: Iżrael

Lingwa: Ingliż

Sors: Ministry of Health

Ingredjent attiv:

PIPERACILLIN AS SODIUM 4 G; TAZOBACTAM SODIUM 0.5 G

Disponibbli minn:

NEOPHARM LTD

Kodiċi ATC:

J01CR05

Għamla farmaċewtika:

POWDER FOR SOLUTION FOR INJECTION

Rotta amministrattiva:

I.V

Manifatturat minn:

WYETH PIPER. DIV.OF WYETH HOLDINGS CORP.

Grupp terapewtiku:

PIPERACILLIN AND ENZYME INHIBITOR

Indikazzjonijiet terapewtiċi:

Antibiotic for the treatment of systemic and/or local bacterial infections caused by susceptible organisms. Tazocin in combination with an aminoglycoside, is indicated for suspected bacterial infections in neutropenic adults or children above 2 years. Appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.

Data ta 'l-awtorizzazzjoni:

2010-06-01